EnglishA study at the ASCO Annual Meeting reveals that Ozempic and Wegovy, known for tackling diabetes and weight loss, might also be cancer's worst enemy! Analyzing over 12,000 patients, researchers found that those on GLP-1 drugs had lower cancer progression rates. But before we pop the confetti, more research is needed to confirm these exciting findings!
Health